Science & research

Crew-12 splashed down at 11:34 a.m. EDT off Los Angeles, and Adenot’s single flight passed the previous European record. NASA and the Energy Department signed a space-nuclear memorandum the same day; it takes effect on November 1.

Science published FRB 20240304B at redshift 2.148, hosted by a low-mass dwarf that is still forming stars. Solar Orbiter read a hot coronal-loop heavy-ion signature inside one magnetic switchback.

Prime editing wrote mouse cell divisions into DNA, and one study reconstructed about 1.28 million cells. An Alzheimer’s paper offers EPHX2 and 12 existing-drug leads. EDIT-401 was cleared to start in Australia, and NVC-001 dosed a first patient.

The chemistry Nobel recognized spontaneous amplification of one molecular handedness, awarded to Kagan and Soai; the same day, Vienna and Tsinghua each published a clock that locks a laser to the thorium-229 nuclear transition.

In spaceflight, Crew-12 undocked at 8:05 a.m. EDT, with splashdown still set for October 8; South Korea’s Nuri rocket placed 15 satellites in orbit on its fifth flight; Hera’s 93-minute main braking burn is scheduled for October 15.

ALMA detected fully deuterated methanol at IRAS 4A2 at about a hundred times the model abundance; the first bond-dissociation energy of seaborgium hexacarbonyl sits below the tungsten homologue, on three events.

Physics: The Nobel Prize in Physics went to Halzen and Antarctic IceCube; the full 12 million Swedish kronor goes to one person, and the detector is the 5,160-sensor array completed in 2011. Pennsylvania State University recast orbital-symmetry selection rules for strongly correlated reactions using zeros of the Green's function.

Space: The six-satellite SunRISE mission will launch no earlier than mid-2027. A Rosalind Franklin prototype drove 220 metres in eight days in a Spanish desert, and on day six drove itself more than 60 metres with under 1% navigation error. Webb released an image of NGC 7129, about 3,300 light-years away.

Biomedicine: Masaka began Phase I dosing of a Bundibugyo Ebola vaccine candidate, with a registry plan for 110 adults. The FDA accepted oral infigratinib, with a PDUFA date of February 4, 2027. Claustrum recordings in seven patients tracked uncertainty and prediction error.

Space: Niobium in white dwarf HS 0209+0832 points to a second-generation planet candidate with a 4.399-day photometric period and no dynamical mass. Crew-12 is scheduled to undock on October 7. The ESA-Vast memorandum is a three-year feasibility study.

Biomedicine: The Nobel Prize in Physiology or Medicine went to optogenetics. VAX-31 met its immunogenicity primary endpoints in 4,047 adults, while serotypes 3 and 12F missed the 0.667 bar against PCV21. Cervavac received WHO prequalification.

Climate and basic research: Ocean acidification under phosphate limitation rewrote diatom phosphorus allocation. In an Ariake Sea model, 4 K of warming lengthened hypoxia by 33.2% for 50- to 100-year discharge events. Detectrons turn RNA into DNA barcodes, and nanogap currents distinguish amino-acid chirality.

Space: Two ESA feasibility studies for a European-led station, led by Airbus and OHB, run about nine months in parallel with commercial-station options, and they are not an approved vehicle.

Biomedicine: Trivalent peramivir–Fc beat baloxavir and CD388 in four influenza mouse models. Rina-S had a 45.9% confirmed response rate in 109 people with platinum-resistant ovarian cancer, in a cohort with no control arm. Seven small proteins connect c-di-GMP to sporulation in C. difficile.

Basic research: Two Asgard archaea crawl on glass using an actin-like cytoskeleton. TBK1/ULK1 phosphorylation of FNIP1 at serine 296 lets TFEB enter the nucleus. Mouse lung tumors can also escape KRAS dependence by turning squamous.

Space: The ExoMars prototype Charlie finished a trial of about two weeks in Tabernas. The flight rover Rosalind Franklin is still planned for a 2028 launch, arrival in early 2030, and a drill to about two meters.

Biomedicine: RAG-18 raised sarcolemmal utrophin 3.5- to 5.3-fold in three boys, with inconsistent walk-test results. Phase 3 retatrutide produced up to 25.0% weight loss on the treatment-regimen estimand at 80 weeks in 2,339 people. A bicyclic-peptide screen found a PD-1 ligand near 400 nM.

Basic research: 624 superior-temporal neurons in three participants support top-down semantic prediction of phonetic activity. Single-spin counts in a strongly attractive Fermi gas still match random-matrix theory. Isobutylammonium cut moisture-driven degradation of a 2D perovskite powder by about sixfold.

Space: Crew-13 completed the fastest U.S. launch-to-docking in 7 hours 55 minutes, and the hatch opened at 9:19 p.m. EDT on Oct 1. The auroral radio report for Beta Pictoris b is a Sept 15 preprint that major outlets carried on Oct 2.

Biomedicine: The FDA approved pirtobrutinib for previously untreated CLL/SLL without a 17p deletion, with a progression-free survival hazard ratio of 0.20 versus chemoimmunotherapy. MCCv flagged a neo-CTCF block at SESN3 among 405 regulatory elements, and pyruvate carboxylase is described as a metabolic dependency in KEAP1-mutant lung cancer under KRAS G12C inhibition.

Climate and energy: The contiguous U.S. had its hottest January-August since at least 1895; a full-year record is estimated at about 80 percent and is not confirmed by NOAA. The Pacific, Atlantic, and Indian Oceans each took about one-third of the extra ocean heat over 20 years. Swedish broccoli under magenta panels used sunlight 4.5 times more efficiently and matured 25 days later.

Space: Crew-13 lifted off at 11:10 a.m. EDT and reached orbit, with docking targeted for 7 p.m. Webb and Spitzer’s 21 extreme debris disks split into eight silica-rich and 13 silica-poor systems.

Biology: An Oxford team reactivated zeta-globin and extended a Hb Bart’s mouse model to embryonic day 17.5. Wave’s RNA-editing drug WVE-006 has FDA alignment on a two-year registrational design, not an approval.

Climate: Swiss glaciers lost 5.5% of their volume this hydrological year and nearly 20% over five years. Antarctica is still very likely to lose ice this century even on a net-zero path, with a high-impact upper case near 10 inches. A Bay Area Kelvin wave could arrive by mid-October.

Space and planets: Roman's fine guidance held better than 1/100,000 of a degree, and the coronagraph took its first focused image. Europe-China Smile was cleared for science, with soft X-ray views of Earth still limited by stray light. Perseverance separated at least three water episodes in Jezero's Margin Unit.

Medicine: Fenebrutinib entered FDA priority review after cutting relapses by about half versus teriflunomide. Lilly's amylin-plus-tirzepatide regimen reached 23.3% weight loss at 48 weeks, with higher dropout. Tau folds copied themselves in wild-type mice, and a type 2 immune history protected mice from lethal flu by limiting damage rather than viral load.

Climate: Carbon Impacts Tracer turns 0.45°C per trillion tonnes of CO2 into eight harm types. The Browse gas project maps to about 200,000 more people facing an extra week of dangerous heat each year.

Spaceflight: Starship Flight 14 reached orbit and deployed 26 Starlink V3 satellites, then ended at 3 hours 8 minutes instead of nearly 10 hours. Juice passed 8,640 km above the Indian Ocean and gained 3.5 km/s.

Medicine: The FDA approved tavapadon, the first selective D1/D5 drug for Parkinson's disease. MIT's solid mRNA lipid nanoparticles kept full bioactivity after more than two months at 37°C. In mice, a temporary block of succinate dehydrogenase improved heart function only when fibroblasts as well as muscle cells were involved.

Earth and energy: ENN announced hydrogen-boron fusion reactions on EXL-50U without a net-energy figure. A national survey of Chinese cropland finds microbial extracellular polymers to be a major source of mineral-associated carbon.

Planetary samples and geology: Bennu's parent is relocated to the water-ice line near Jupiter, and Mercury's radial contraction is revised from 8.3 km to 11.6 km.

Radio astronomy: a 1.2-megaparsec S-shaped giant is proposed as a four-episode jet prototype, still as a preprint.

Life and medicine: two courses of blinatumomab replace intensive chemotherapy in pediatric high-risk B-ALL (4-year event-free survival 83.0% versus 70.3%); reef-fish gills host bacteria with chemosynthetic potential, and a synchrotron scan of a whole mantis-shrimp eye reveals an undescribed tube network.

Space headlines pair routine reusable national-security launches with a Starship first-orbit countdown, while Enceladus habitability and plume-grain chemistry advance in tandem.

JWST keeps rewriting cosmic dawn: early galaxies were already seeding heavy elements needed for planets and life.

Biomedicine splits between application wins (in-body ionic networking; pediatric alopecia approval) and a regulatory reset (ADC accelerated-approval withdrawal).

Space ops advanced on the same day via Crew-13 readiness review, Cygnus reboost, Roman ground-station acceptance, and Juice’s third Earth flyby countdown.

Biomedicine paired MSK nanotherapy against tumor fibrosis with first-in-human prime editing for AATD, while an all-family bat genome atlas reframed European origins.

Energy and environment headlines spanned a lead-free tin perovskite stability claim, Gobi solar dust co-benefits, and a chlorine-enabled Li–S third-electron chemistry.

NASA locks in far-infrared Probe PRIMA while Beta Pictoris b radio pinning and Perseverance’s hot-groundwater record lift deep-space and habitability narratives the same day.

Lilly’s weekly basal insulin wins FDA approval and Kyverna’s autoimmune CAR-T posts one-year durability—metabolic and cell-therapy pipelines hit filing/launch windows.

Longi’s silicon-cell record and Gobi solar–dust modeling extend the energy transition story from generation into air-quality co-benefits.

Space: Ramses powers on into integrated testing; Artemis III’s ~90-day slip puts dual 2028 landings under pressure.

Biomedicine: sefaxersen and ulefnersen post Phase 3 RNA-therapy wins; bitopic kinase design and a trypanosomatid trans-spliceosome structure widen the target map.

Brain and climate: PsychAD’s prefrontal single-cell atlas drops; land heatwaves are quantified as earlier, faster and longer-seasoned, while the UN elevates grid bottlenecks at the Climate Summit.

Exoplanet magnetism gets a first direct radio “tape measure” (β Pic b), while Jezero’s Margin Unit is rewritten as a multi-episode water–rock history.

Rare disease and PAH: AQNEURSA opens an A-T indication; WINREVAIR’s label now carries year-one HYPERION evidence.

Climate tech advances on two fronts: electrochemical DAC pilots near ~0.83 MWh/t and ambient perovskite–silicon tandems at 33.0% certified.

Space: Roman’s WFI records its first starlight test frame; ESA FLEX begins fluorescence-based plant monitoring; JWST compresses brown-dwarf weather into temperature and cloud modes; neutrino flavor conversion enters explode-or-collapse simulations.

Biomedicine: 4D mitochondrial virtual cells enter the drug-screen toolkit; FAYUVI becomes the first approved gene therapy for Sanfilippo syndrome type A; a domestic influenza mRNA vaccine clears clinical-trial entry in China.

Energy & climate: perovskite/silicon tandems hit 34% lab efficiency and a certified 2.014 V Voc; wide-bandgap perovskites deliver usable power at 10 m depth.

Space: NASA bought three more SpaceX crew flights for $946 million, taking the contract to 17 missions through 2030; XRISM saw stellar wind falling onto a pulsar; Yale pushed chondrule sorting back to the Solar System's first million years.

Biomedicine: Inluriyo plus Verzenio won full approval, with median progression-free survival of 11.1 versus 5.5 months in ESR1-mutated disease; a first mutation-matched antisense oligonucleotide left a man with rare motor-neuron disease still practicing a year later; m6A can lock or release pancreatic alpha-cell identity.

Climate: extreme-heat area in central and northwest India grew about 20%–40% per decade; human nitrogen exceeds all natural sources along about a quarter of coastal segments.

Space: Roman’s wide-field camera recorded its first unfocused starlight, and ESA assigned the EU governmental Earth-observation architecture study to the ICEYE-led ARISE consortium.

Biomedicine: Fayuvi is the first approved gene therapy for Sanfilippo type A; Stanford separated forebrain and hindbrain progenitor lineages; dersimelagon entered Priority Review.

Climate and energy: about 11.3 trillion tonnes of polar ice loss is mostly dynamic discharge; the ocean set same-day heat records for 100 days; a GE-crop briefing and a seawater hydrogen device landed the same day.

Space: Roman’s propellant lifetime potential jumps to ~22 years; Galileo SAS posts a first civil authenticated fix under spoofing; lunar crater McGetchin rewrites near-field impact expectations.

Biomedicine: levetiracetam targets synaptic “theft” in childhood DMG; Kerendia fills a T1D kidney gap; Enspryng races toward a first MOGAD DMT.

Climate & energy: Himalayan compound-hazard attribution, squid brain shrinkage under acidification, European green-hydrogen spatial policy, and perovskite buffer process advances move in parallel.

Stanford’s “xenocortical mice” lead the day in Nature, advancing human cortical organoids to circuit- and behavior-level in vivo readouts.

Space tracks advance in parallel: Starship’s first orbital window, confirmation of youngest exoplanet Elias 2-24 b, and Roman’s primary camera activation.

Climate ledgers thicken: IMBIE shows ~84% of polar ice loss from faster glacier flow; heat-driven labor losses enter the social cost of carbon.

European Earth observation hit an operational milestone: FLEX and Sentinel-3C reached orbit together, boosting vegetation fluorescence science and Copernicus marine–land monitoring.

Physics advanced on two fronts: ATLAS reported strong evidence for Z-boson entanglement from Higgs decays, while a silicon chip integrated a full frequency-domain quantum processing chain.

Biomedicine paired a glycogen quality-control mechanism and interferon-driven hematopoietic reprogramming with an FDA IND acceleration pilot and IgAN Phase 3 data showing eGFR stabilization.

Europe’s dual Earth-observation satellites near launch and a Hubble/JWST deep TNO census put “watching Earth” and “watching the outer Solar System” on the same day’s agenda.

LZ’s 2.6σ dark-matter hint, a superthermal muonium beam, and on-chip all-optical magnetic switching run in parallel as clue, tool, and device.

Multimodal BCI, squamous-NSCLC immunotherapy survival data, and a de novo–mutation/ART research briefing mark a dense translational neuro–oncology–genomics day.

Dual space-weather alerts: Earth’s extreme geomagnetic response may lack a cozy ceiling, while BepiColombo captured in situ SEP shielding and leakage at Mercury.

Astronomy and cosmology tighten fundamentals: Chariklo’s year-scale ring evolution revises small-body ring stability, and LBT primordial helium at 0.5% precision reinforces Standard Model cosmology tests.

Biomedicine spans “stop death,” “split disease,” and “start sleep”: covalent BAX blockade, myeloma archetypes plus FCRL2, and cortical sleep-promoting neurons.

Space: NASA–IBM’s lunar foundation model turns orbital archives into fine-tunable tools; Hubble catches a strengthening southern Saturnian decagon jet wave.

Biomedicine: WHOLISTIC opens whole-body cellular circuit imaging; Isembyld and pediatric Joenja advance rare-disease access; densely modified pegRNAs push non-viral prime editing toward clinically relevant doses.

Climate/environment: Science quantifies storm-driven microplastic river pulses concentrated in the Global South; China’s rarest extreme downpours show a strengthening human fingerprint.

Space: GPS-free optical navigation and FAST’s HI census both advance “see it, then navigate/catalog it” infrastructure.

Astronomy: kine turns VLBI stills into measurable jet velocity fields, challenging shock narratives for 3C 345.

Biomedicine: asthma core-gene tools, Alexander disease’s first disease-modifying drug, dual TTR unfolding paths, and a new tick-borne virus shared the day.

Climate monitoring and feedback science spoke on the same day: August tied the hottest month and again exceeded 1.5°C, while natural sources may amplify warming by roughly one-fifth to one-third.

Space ran dual tracks of data infrastructure and European access autonomy: NASA–IBM’s lunar foundation model went open, and the Paris summit locked in Nyx/ALADDIN while debating crewed timelines.

In biomedicine, a generative-AI drug entered Phase III for IPF, China’s third-generation COVID mRNA vaccine won approval, and menstrual-migraine prevention posted a positive Phase 3 readout.

OpenAI published a Navier–Stokes-related proof with Lean formalization, but the Clay Institute has not accepted a solution and prize criteria remain contested.

Hubble–Webb reveal fewer ultrafaint TNOs than expected; MTG-I2 reaches orbit and Earth–Moon laser-link coverage expands the space/weather beat.

Bianfu Cave Denisovan fossils and subsistence evidence headline Nature; GlyphAllo driving safety plus mosliciguat/HPV trials advance biomedicine.

Space: Stoke's billion-dollar bet on full reuse and larger lift; Isar's weekend orbit redraws Europe's commercial launch map; FAST anchors a cluster-origin pathway for disk neutron stars.

Biomedicine: A pan-Ras oral drug rewrites metastatic pancreatic cancer narratives; IRIS, bystander T-cell killing, and BAFF-R CAR-T advance developmental decoding, immuno-mechanisms, and clinical depth; China's flu mRNA vaccine enters trials.

Climate: Svalbard meltwater methane and the PKU CH₄-plateau mechanism—opposite ends of the same lesson—put glacial feedbacks and atmospheric oxidizing capacity into policy models.

Space: BepiColombo jettisons its transfer module into a six-month Mercury arrival sequence; China’s Earth–Moon laser link and Cube constellation plan heat up together.

Biomedicine: In vivo CAR-T plus MLC1/ALTNV mechanism and pathogen finds arrive alongside an Lp(a)-lowering hard-endpoint miss—markers ≠ outcomes.

Climate & energy: WMO flags wildfire–heatwave feedbacks undoing clean-air gains; perovskite efficiency and multi-thousand-hour stability advance in parallel.

European commercial launch: Spectrum’s second flight reaches orbit, delivering fully commercial European orbital capability.

Mars organics and sample-return urgency resurface; on the vaccine side, GSK advances HA+NA mRNA flu into Phase III.

Climate: Arctic melt season lengthens by about a week; storage: 3D-printed electrodes target flow-battery mass transport.

Space: BepiColombo begins Mercury arrival; China’s cislunar CubeSat network and Tianwen-3 landing-site work advance deep-space infrastructure.

Life sciences: Chromatin loops prove mostly fleeting; the male fly CNS connectome and chimeric mRNAs rewrite genome and circuit maps.

Climate & energy: UNEP shifts to “overshoot management,” while Korea’s thin-film tandem solar efficiency sets a new record.

Space: Mars dedicated telecom network awarded; ultraheavy dark-matter mass window opened; a centaur caught mid-transition to comet activity.

Biomedicine: Live-cell longitudinal transcriptomics arrives; Alexander disease and FOP gain approved therapies; China-made RSV long-acting mAbs break the import monopoly.

Climate & energy: Very strong El Niño warnings extend into early 2027; China’s solar capacity overtakes coal while generation share still trails.

Space: BepiColombo’s MTM separation opens the Mercury dual-orbiter arrival sequence.

Fundamentals: quantum free-fall phase, male fly connectome, spin-controlled surface chemistry, and AI experiment design all heated up.

Biomedicine: in vivo CAR-T proof-of-concept, a positive myeloma bispecific Phase 3, and a China GPC3 ADC FDA IND form a ladder of progress.

Space: Blue Origin wins the Mars telecom network award; ISS EVA-99 closes navigation and science-maintenance tasks.

Biomedicine: Chimeric mRNAs, a corisin fibrosis mechanism, GSK’s flu Phase III plans, and a China bispecific ADC advance from mechanism to pipeline.

Energy materials: Perovskite–CIGS small-area efficiency and lead-free tin perovskite stability move in parallel.

Particle physics: LZ’s ~2.6σ single-event dark-matter hint opens a global cross-check window.

Spaceflight: An ISS all-female EVA and BepiColombo’s Mercury-arrival eve shared the day’s agenda.

Climate hazards: Gyirong’s “en-route mass gain” mechanism and a global SST record put cryosphere risk and ocean heat inertia on the same stage.